Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients
| Autor: | Nina Chanishvili, Aras Kadioglu, Craig Winstanley, Martha R. J. Clokie, Christopher O'Callaghan, Claire Smith, Jaspreet Singh Sahota, Priya Radhakrishnan, Marina Goderdzishvili |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Pulmonary and Respiratory Medicine
Phage therapy Cystic Fibrosis medicine.drug_class medicine.medical_treatment Antibiotics Clone (cell biology) Pharmaceutical Science medicine.disease_cause Cystic fibrosis Microbiology Bacteriophage medicine Humans Pharmacology (medical) Pseudomonas Infections Virus quantification biology Pseudomonas aeruginosa Nebulizers and Vaporizers biology.organism_classification medicine.disease Virology Biological Therapy Burkholderia cepacia complex Phenotype Pseudomonas Phages |
| Zdroj: | Journal of aerosol medicine and pulmonary drug delivery. 28(5) |
| ISSN: | 1941-2703 |
| Popis: | The rise in antibiotic-resistant Pseudomonas aeruginosa and the considerable difficulty in eradicating it from patients has re-motivated the study of bacteriophages as a therapeutic option. For this to be effective, host range and viability following nebulization need to be assessed. Host-range has not previously been assessed for the Liverpool Epidemic Strain (LES) isolates that are the most common cystic fibrosis-related clone of P. aeruginosa in the UK. Nebulization studies have not previously been linked to clinically relevant phages.84 phenotypically variable isolates of the LES were tested for susceptibility to seven bacteriophages known to have activity against P. aeruginosa. Five of the phages were from the Eliava Institute (IBMV) and 2 were isolated in this study. The viability of the two bacteriophages with the largest host ranges was characterized further to determine their ability to be nebulized and delivered to the lower airways. Phages were nebulized into a cascade impactor and the phage concentration was measured.The bacteriophages tested killed between 66%-98% of the 84 Liverpool Epidemic Strain isolates. Two isolates were multi phage resistant, but were sensitive to most first line anti-Pseudomonal antibiotics. The amount of viable bacteriophages contained in particles that are likely to reach the lower airways (4.7 μm) was 1% for the Omron and 12% AeroEclipse nebulizer.Individual P. aeruginosa bacteriophages can lyse up to 98% of 84 phenotypically diverse LES strains. High titers of phages can be effectively nebulized. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|